BRIC IVD Market 2017 by Product & Service, Technology, Application - Forecast to 2022 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "IVD Market in BRIC by Product & Service (Instruments, Reagents, Software), Technology (Immunoassay, Hematology, Microbiology), Application (Diabetes, Cardiology, Infectious Diseases), Country (Brazil, Russia, India, China) - Forecast to 2022" report to their offering.

The IVD market in BRIC is expected to reach USD 15.71 billion by 2022 from USD 10.60 billion in 2017, at a CAGR of 8.2%

The key factors driving the growth of the market are growing patient awareness of personalized medicine, increasing prevalence of lifestyle and chronic diseases, growth in the number of private diagnostic centers, and improving healthcare system in emerging countries. However, market growth is restrained by the lack of reimbursement and the slow growth of the economy in some emerging countries.

Market Dynamics

Market Drivers

  • Rising Incidence of Chronic Lifestyle Diseases
  • Rapid Growth in the Geriatric Population
  • Increasing Adoption of Point-Of-Care Testing
  • Growing Awareness of Personalized Medicine
  • Growth in the Number of Private Diagnostic Centers

Market Restraints

  • Inadequate Reimbursement
  • Economic Slowdown in Latin America

Market Opportunities

  • Improving Healthcare Systems in Emerging Markets
  • Growing Significance of Companion Diagnostics

Market Challenges

  • Stringent Regulatory Framework in Latin America
  • Operational Barriers to the Use of Diagnostic Tests

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Industry Insights

6 BRIC IVD Market Overview

7 BRIC IVD Market, By Product & Service

8 BRIC IVD Market, By Technology

9 BRIC IVD Market, By Application

10 BRIC IVD Market, By End User

11 Geographic Analysis: BRIC IVD Market

12 BRIC IVD Market Competitive Landscape

13 Company Profiles

  • A.Menarini Diagnostics Ltd.
  • Abbott Laboratories Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Biomerieux SA
  • Danaher Corporation
  • Diasorin S.P.A.
  • Erba Diagnostics Inc.
  • Hologic Inc.
  • Illumina Inc.
  • Johnson and Johnson Inc.
  • Mindray Medical International Limited
  • Ortho Clinical Diagnostics Inc.
  • Qiagen N.V.
  • Quidel Corporation
  • Roche Diagnostics
  • Siemens Healthineers
  • Span Divergent Ltd.
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech PLC.
  • Werfen Life Group S.A.

For more information about this report visit http://www.researchandmarkets.com/research/ls6hzq/ivd_market_in

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: In Vitro Diagnostics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: In Vitro Diagnostics